A Randomized, Double-Blind, Phase 2, Dose-Ranging Study to Evaluate the Safety and Efficacy of Veliparib and Whole Brain Radiation Therapy Versus Placebo and Whole Brain Radiation Therapy in Subjects With Brain Metastases From Non-Small Cell Lung Cancer
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Overall Survival
Survival assesments are performed for up to 36 months
No
Vincent Giranda, MD
Study Director
AbbVie
Australia: Department of Health and Ageing Therapeutic Goods Administration
M10-897
NCT01657799
October 2012
November 2014
Name | Location |
---|---|
Site Reference ID/Investigator# 68494 | Goshen, Indiana 46526 |
Site Reference ID/Investigator# 68311 | Farmington Hills, Michigan 48334 |
Site Reference ID/Investigator# 68495 | Birmingham, Alabama 35233 |
Site Reference ID/Investigator# 65828 | Chandler, Arizona 85224 |
Site Reference ID/Investigator# 66052 | Tucson, Arizona 85724 |
Site Reference ID/Investigator# 92618 | Tucson, Arizona 85704 |
Site Reference ID/Investigator# 92623 | Tucson, Arizona 85704 |
Site Reference ID/Investigator# 65832 | Los Angeles, California 90033 |
Site Reference ID/Investigator# 96255 | Los Angeles, California 90033 |
Site Reference ID/Investigator# 72793 | San Francisco, California 94115-1705 |
Site Reference ID/Investigator# 92616 | Lone Tree, Colorado 80124 |
Site Reference ID/Investigator# 68161 | Deerfield Beach, Florida 33442 |
Site Reference ID/Investigator# 66025 | Chicago, Illinois 60611 |
Site Reference ID/Investigator# 81813 | New Albany, Indiana 47150 |
Site Reference ID/Investigator# 65830 | Detroit, Michigan 48202 |
Site Reference ID/Investigator# 84773 | Lansing, Michigan 48912 |
Site Reference ID/Investigator# 80473 | Hackensack, New Jersey 07601 |
Site Reference ID/Investigator# 68317 | Manhasset, New York 11030 |
Site Reference ID/Investigator# 69291 | Philadelphia, Pennsylvania 19141 |
Site Reference ID/Investigator# 70553 | Philadelphia, Pennsylvania 19104 |
Site Reference ID/Investigator# 73993 | Philadelphia, Pennsylvania 19124 |
Site Reference ID/Investigator# 92614 | Arlington, Texas 76014 |
Site Reference ID/Investigator# 66703 | Dallas, Texas 75390 |
Site Reference ID/Investigator# 92615 | Denton, Texas 76210 |